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INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is a primary my-
ocardial disease, characterized by left ventricular hy-
pertrophy (LVH), normal or supernormal systolic func-
tion and impaired diastolic function, including chamber
stiffness and impaired relaxation (1, 2).
Active relaxation is an energy-consuming process,
and its impairment in HCM may be related to abnormal
calcium kinetics (3), subendocardial ischemia (4), non-
uniform temporal and regional distribution of load and
inactivation (5). 
An increase in chamber stiffness reflects abnormali-
ties in the intrinsic elastic proprieties of the myocardi-
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ABSTRACT: Background. Hypertrophic cardiomyopathy (HCM) is characterized by asymmetric
LV hypertrophy (LVH) and impairment in diastolic function. We assess the relationship between
LVH and invasive indexes of diastolic function.
Methods. 21 HCM patients underwent cardiac catheterization to assess pulmonary capillary
wedge pressure, LV end-diastolic pressure (measured by microtip catheters), and LV volumes
(calculated by simultaneous radionuclide angiography). We calculated from LV pressure the time
constant of isovolumetric relaxation (τ, variable asymptote method, ms), and from LV pressure
and volume the constant of chamber stiffness (k, ml-1). LVH was assessed by different indexes:
maximal wall thickness, number of hypertrophied LV segments, LVH index, and Wigle’s score. 
Results. Wigle’s score was directly related to pulmonary capillary Wedge pressure (r=0.436,
p=0.048), peak V wave of pulmonary capillary wedge pressure (r=0.503, p=0.024), LV end-dias-
tolic pressure (r=0.643, p=0.002) and k (r=0.564, p=0.015). HCM patients were divided into 2
groups according to Wigle’s score: 10 with mild or moderate LVH (< 8), and 11 with severe LVH
(≥ 8). HCM patients with severe LVH showed a higher pulmonary capillary Wedge pressure
(15.1±7.2 vs 9.5±2.4, p=0.033), peak V wave of pulmonary capillary wedge pressure (20.7±4.6
vs 14.6±4.9, p=0.011), LV end-diastolic pressure (23.9±10.9 vs 10.6±2.5, p=0.002), k
(0.0465±0.032 vs 0.015±0.007, p=0.022) and LV outflow tract gradient (72±36 mmHg vs 29±30
mmHg, p=0.01). τ was similar in the two groups. Other indexes of LVH were not related to dias-
tolic function.
Conclusions. Wigle’s score is the only index of LVH that relates to invasive indices of diastolic
function. (Heart International 2006; 2: 106-14)
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um. One possible cause is increased interstitial fibrosis,
often associated with the high degree of hypertrophy
and myocyte disorganization (6). This increase in cham-
ber stiffness results in an increased diastolic pressure
with respect to volume, hence, the diastolic pressure
volume curve is shifted upward and/or to the left (7).
Although hypertrophy is the synonym of HCM, the re-
lationship between LVH and impaired diastolic function
has not been clearly demonstrated in patients with
HCM. This is mostly due to the inherent difficulty in
measuring LVH in HCM: the classical echocardiograph-
ic formula for mass measurement (8) implies an ellip-
soidal LV cavity with constant wall thicknesses which
does not hold true HCM. 
Spirito et al (9) reported that impaired LV relaxation,
determined by means of Doppler mitral inflow veloci-
ties, is not related to the magnitude of LV hypertrophy,
assessed as a sum of maximal wall thickness in four
ventricular segments. However, in a previous study (10),
using M-mode echocardiography techniques, the same
authors found a relation between the extent of LVH and
impaired relaxation. Moreover, Wigle and co-workers
(11) demonstrated a direct relationship between LV end-
diastolic pressure and the extent of LVH, and our group
showed that diastolic filling varies in different regions of
the LV and is influenced by regional septal thickness
(12).
The aim of our study was to assess if a relationship
exists between magnitude and distribution of LVH and
invasive indexes of LV diastolic function in HCM.
METHODS
Patient population. Twenty one consecutive patients
with HCM, aged 37±14 years (12 males) from the car-
diomyopathy outpatient clinic at Federico II University
School of Medicine were enrolled. The diagnosis of
HCM was based on the echocardiographic evidence of
hypertrophic, nondilated left ventricles without appar-
ent cause, such as systemic hypertension, aortic steno-
sis etc. (13). All patients were in normal sinus rhythm,
and had no atrioventricular conduction abnormalities or
left or right bundle branch block. All cardioactive med-
ications were withdrawn for at least five half-lives before
the study.
Echocardiography. Each patient underwent standard
M-mode, 2-dimensional and color Doppler echocardio-
graphy. Echocardiograms were performed using a
Hewlett-Packard ultrasonic scanner (Sonos 1000, Han-
dover, MA) equipped with 2.5 MHz and 1.9 MHz trans-
ducers. M-mode echocardiograms were obtained from
the 2-dimensional images under direct anatomic visual-
ization. Left atrial, LV end-diastolic and end-systolic di-
ameters were measured according to the guidelines of
the American Society of Echocardiography (14). LV hy-
pertrophy was evaluated by different indexes:
a) a point score system, the Wigle’s score, which takes
into account the thickness of the ventricular septum,
the presence of septal hypertrophy at papillary or api-
cal levels, and the presence of anterolateral wall ex-
tension of hypertrophy; the score is the sum of these
factors, spanning from 0 to 10 (Fig. 1) (11).
b) Sum of the maximal wall thickness measured in the
short axis view at either mitral valve or papillary mus-
cle level in each of the 4 ventricular segments (anteri-
or and posterior septum, posterior and lateral walls)
(hypertrophy index) (9)
c) number of hypertrophied LV segments (10)
d) maximal wall thickness (15).
Color Doppler flow imaging was used for identifying
and semiquantitatively estimating mitral regurgitation
(16). Peak LV outflow tract gradient was recorded, both
at rest and during provocation by amyl nitrite inhalation,
by a 1.9 MHz non-imaging transducer, using the simpli-
fied Bernoulli equation (P=4V
2, where P is pressure and
V is flow velocity). Care was taken to distinguish ejec-
tion velocity from the mitral regurgitation jet (17).
Cardiac catheterization and hemodynamic measure-
ment. All patients underwent cardiac catheterization for
diagnostic purposes (exercise-induced chest pain or
assessment of LV outflow tract gradient). A 7Fr Swan-
Ganz thermodilution catheter (Edwards Laboratories
Inc., Santa Ana, California) was introduced into the pul-
monary artery to measure pulmonary artery and wedge
pressures, and cardiac output (average of 3 determina-
tions).
A 7Fr pigtail high-fidelity transducer-tipped catheter
(Sentron v.g.f., Roden, The Netherlands) was intro-
duced through a 9Fr arterial sheath into the left ventri-
cle. Systemic arterial pressure was monitored through
the side port of the 9Fr arterial sheath: this size, 2Fr big-
ger than that of the catheter, was selected to allow reli-
able recording of the arterial pressure. The LV outflowHypertrophy and diastolic function in hypertrophic cardiomyopathy
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tract gradient was defined as peak-to-peak difference
between the LV and arterial pressures (18, 19). It was
measured at rest in all patients and during amyl nitrite
inhalation in those with resting gradients <30 mmHg.
LV pressure and its first derivative (dP/dt) were
recorded at a paper speed of 250 mm ⋅ s
-1, and sent to
the gamma camera-computer system to build pressure-
volume curves.
High-speed LV pressure was digitized at high tempo-
ral resolution (≤ 4 ms) for calculation of the time-con-
stant of isovolumetric relaxation τ using the shifting 
asymptote technique (20). Digitization started from min-
imal dP/dt and ended when LV pressure was 5 mmHg
above the following end-diastolic pressure. From the
equation P= Pa+P0eατ (where P is pressure, τ is time, Pa
is the pressure asymptote, and P0 is LV pressure at the
beginning of isovolumetric relaxation), the time-con-
stant of isovolumetric relaxation τ was calculated, as τ =
-1/α by nonlinear curve fitting (SPSS for Windows, ver-
sion 10.0).
Left ventriculography was performed in the 30° right
anterior oblique position. The end-diastolic volume was
measured (21) on the first well-opacified sinus beat not
following an ectopic beat by a graphic tablet interface
with a computer; the volume was used to convert the ra-
dionuclide angiographic counts into milliliters, as de-
scribed below. To minimize the differences in body size
between patients, cardiac output, systemic vascular re-
sistances, and LV volumes were normalized to the pa-
tient’s body surface area. For diagnostic purposes,
coronary arteriography in multiple views was performed
in patients aged ≥ 40 years.
Radionuclide angiography. Equilibrium radionuclide
angiography was done with patients lying on the car-
diac catheterization cradle in the supine position by a
small field-of-view gamma camera (LEM ZLC Siemens
Gammasonics, Des Plaines, Illinois) in a 45° left anterior
oblique view with a 15° caudal tilt. Red blood cells were
labeled in vivo with 740 to 945 MBq of Technetium99m.
Electrocardiographic-gated images were acquired with
a 2X digital zoom, at 50 frames ⋅ s-1. At least 150,000
counts/frame were collected in the baseline study.
Time-activity curves represent the average of many car-
diac cycles (as many as needed to acquire a sufficient
counts statistic); they were corrected for isotope decay
at baseline and expressed in milliliters by normalizing
their end-diastolic counts to end-diastolic volume mea-
sured by contrast angiography. 
Fig. 1 - Scheme to as-
sess the Wigle’s score,
a point score system
which takes into ac-
count the thickness of
the ventricular septum
(1= between 15 and 19
mm, 2= between 20 and
24 mm, 3= between 25
and 29 mm, and 4= ≥ 30
mm), the presence of
septal hypertrophy at
papillary (scored as 2)
and/or apical (scored as
2) levels, and the pres-
ence of anterolateral
wall extension of the hy-
pertrophy (scored as 2).
The total score is the
sum of these individual
factors and spans from
0 to 10.Ciampi et al
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Ejection fraction was calculated on unfiltered time-
activity curve. Peak filling rate was calculated after fil-
tering by a Fourier expansion with 5 harmonics. It was
measured in ml ⋅ s-1 and further normalized by end-di-
astolic and stroke volumes. 
Left ventricular pressure-volume analysis. LV pres-
sure was sent to a custom-designed interface (Medie
s.r.l., Milan, Italy) connected to the gamma camera-
computer system, as previously described (18, 19); this
device writes pressure data into the counts matrix: in
this way, the obtained pressure points correspond to
the volume points. By plotting pressure as a function of
volume we built pressure-volume curves. The LV con-
stant of chamber stiffness (k) was measured by using
the elastic model with shifting asymptote method (20).
Calculation was made from minimum pressure to end-
diastole, by the formula P = B + AekV, where P is pres-
sure, V is volume, A and k are fitting constants, and B
the pressure asymptote. Fitting was achieved by a com-
puter program that allows nonlinear fitting (SPSS for
Windows, version 10.0).
Statistics. Data was expressed as mean ± 1 standard
deviation. Univariate and multivariable logistic regres-
sion analyses were performed. Unpaired Student’s t-
test was done to determine differences for continuous
variables between the 2 HCM groups: mild or moderate
LVH (Wigle’s score <8) and severe LVH (Wigle’s score
≥8). When appropriate, chi-square test with Yate’s cor-
rection for continuity was used to analyze categorical
variables. A probability value of <0.05 was considered
statistically significant. All statistical calculations were
performed by SPSS for Windows, release 10.0 (Chica-
go, Illinois).
RESULTS
Patient characteristics. The clinical, echocardio-
graphic and invasive baseline characteristics of the 21
HCM patients are shown in Table I. Atrial enlargement
was evident in 11 patients (52%). Mitral regurgitation
was found in 11 patients, and was semiquantitatively
ranked mild in 8 patients, moderate in 1 patient, and se-
vere in 2 patients. By both catheterization and Doppler
echocardiography, 14 patients (67%) showed a signifi-
cant LV outflow tract gradient at rest (≥ 30 mmHg),
whereas 3 of the remaining 7 patients developed a sig-
nificant (≥ 50 mmHg) gradient during provocation by
amyl nitrate inhalation. Patients who underwent coro-
nary angiography had normal coronary arteries.
LV hypertrophy and diastolic function
Wigle’s score was directly related to pulmonary cap-
illary Wedge pressure (r=0.436, p=0.048, Fig. 2-A), peak
V wave of pulmonary capillary wedge pressure (r=0.503,
p=0.024), LV end-diastolic pressure (r=0.643, p=0.002,
Fig. 3-A) and k (r=0.564, p=0.015 Fig. 4-A). LV end-dias-
tolic volume was inversely related to Wigle’s score (r=-
0.503, p=0.024). 
The HCM patients were also divided into 2 groups ac-
cording to Wigle’s score: 10 HCM patients with mild or
moderate LVH (< 8), and 11 HCM patients with severe
LVH (≥ 8). The clinical, echocardiographic and invasive
baseline characteristics of the 2 HCM patients groups
are shown in Table II. HCM patients with severe LVH,
compared to patients with mild or moderate LVH,
showed a higher pulmonary capillary Wedge pressure
(p=0.033, Fig. 2-B), higher peak V wave of pulmonary
artery wedge pressure (21±5 vs 14±5, p=0.011), higher
LV end-diastolic pressure (p=0.002, Fig. 3-B), and high-
er constant of chamber stiffness (k, p=0.022, Fig. 4-B).
TABLE I - THE CLINICAL, ECHOCARDIOGRAPHIC AND INVA-
SIVE BASELINE CHARACTERISTICS OF THE HCM 
PATIENTS
Age (years) 37±14
Males (%) 11 (52)
Heart rate (beats/min) 80±10
Maximal wall thickness (mm) 27±6 
LV outflow tract gradient (mmHg) 52±40
Cardiac index (Lmin-1/m
2) 3.1±0.9
Pulmonary capillary wedge pressure (mmHg) 12±6
Peak V wave of pulmonary artery wedge 
pressure (mmHg) 18±6
LV pressure (mmHg) 
Systolic 167±41
End-diastolic 18±10
LV volumes (ml/m2)
End-diastolic 79±28
End-systolic 15±14
Ejection fraction (%) 83±12
LV: left ventricularHypertrophy and diastolic function in hypertrophic cardiomyopathy
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HCM patients with severe LVH showed higher degree of
LV outflow tract gradient (72±36 mmHg vs 29±30
mmHg, p=0.01). Time-constant of isovolumetric relax-
ation τ was not different in the two groups. 
There was no relationship determined between the
other indexes of LV hypertrophy and diastolic function
assessed.
In multiple regression analysis, Wigle’s score was the
only index of LV hypertrophy predictor of higher pul-
monary capillary Wedge pressure (F=4.455, p=0.048),
higher LV end-diastolic pressure (F=13.347, p=0.002)
and higher constant of chamber stiffness (F=7.465,
p=0.015).
DISCUSSION
In this paper, we demonstrated that the magnitude
and distribution of LV hypertrophy, assessed by Wigle’s
score, were related to invasive indexes of passive dias-
tolic dysfunction. In fact, we demonstrated that HCM
patients with severe LV hypertrophy (Wigle’s score ≥8)
showed higher pulmonary capillary wedge pressure
(Fig. 1), LV end-diastolic pressure (Fig. 2), and constant
of chamber stiffness (Fig. 3).
LV hypertrophy, fibrosis and diastolic function
LV chamber stiffness is increased by virtue of the in-
crease in muscle mass, decrease in ventricular volume,
and increase in muscle stiffness, caused by myocardial
fibrosis (6). The association of hypertrophy, disarray,
and increased interstitial fibrosis leads to a stiffer LV
wall: this implies that the diastolic pressure-volume re-
lationship moves leftward and slightly upward as com-
pared to the normal (7).
Diastolic dysfunction is primarily due to myocardial
hypertrophy and fibrosis (22). Our group demonstrated
a remodeling in the extracellular matrix composition in
HCM: as collagen synthesis prevails over degradation,
passive diastolic dysfunction occurs (23). Varnava et al
showed that the magnitude of hypertrophy correlated
with the severity of fibrosis and disarray (24). Further-
more, they found that interstitial fibrosis increased with
age and was directly related to maximal wall thickness,
while disarray was present at an early age and dimin-
ished with time. For this reason, these authors suggest-
ed that myocyte disarray is a direct response to func-
tional or structural abnormalities of the mutated sar-
comeric protein, while fibrosis and hypertrophy are lat-
er, secondary responses. 
TABLE II - THE CLINICAL, ECHOCARDIOGRAPHIC AND INVASIVE BASELINE CHARACTERISTICS OF THE HCM PATIENTS WITH
WIGLE’S SCORE <8 AND ≥8
Wigle’s score <8 Wigle’s score ≥8 p
Number 10 11
Age (years) 36±13 39±14 N.S.
Males (%) 5 (50) 6 (54) N.S.
Heart rate (beats/min) 79±11 82±8 N.S.
Maximal wall thickness (mm) 25±6  28±7  N.S.
Maximal wall thickness ≥30 mm 3 (30%) 4 (36%) N.S.
LV outflow tract gradient (mmHg) 29±30 72±30 0.01
Significant LV outflow tract gradient  6 (60%) 10 (91%) N.S.
Cardiac index (Lmin-1/m2) 3.2±1.1 3.1±0.8 N.S.
Pulmonary capillary wedge pressure (mmHg) 9±2 15±7 0.033
Peak V wave of pulmonary artery wedge pressure (mmHg) 14±5 21±5 0.011
LV pressure (mmHg) 
Systolic 149±38 183±39 0.05
End-diastolic 11±2 24±11 0.002
LV volumes (ml/m2)
End-diastolic 89±33 67±15 0.077
End-systolic 19±16 10±7 N.S.
Ejection fraction (%) 81±14 85±10 N.S.
LV: left ventricularCiampi et al
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Spirito and Maron (9) reported that impaired LV relax-
ation is not necessarily related to magnitude of LV hy-
pertrophy. They assessed LV relaxation by means of
Doppler mitral inflow velocities, but if internal or exter-
nal restoring forces, or both, are excessive (11) or if left
atrial pressure is markedly elevated in cases of exten-
sive hypertrophy, indexes that reflect LV relaxation
could fall within the normal range (pseudonormalization)
Fig. 2 - A) Pulmonary capillary wedge pressure plotted as a function of the Wigle’s score. Curved lines show 95% confidence limits for the
fitted line. B) Individual values of pulmonary capillary wedge pressure in patients with Wigle’s score <8 (open circle) and ≥8 (closed circle).
Closed squares with vertical bars represent mean value ± 1 SD. The grey box indicates the mean value ± 2 SD of the patients with Wigle’s
score <8. 
Fig. 3 - A) LV end-diastolic pressure plotted as a function of the Wigle’s score. Curved lines show 95% confidence limits for the fitted line.
B) Individual values of LV end-diastolic pressure in patients with Wigle’s score <8 (open circle) and ≥8 (closed circle). Closed squares with
vertical bars represent mean value ± 1 SD. The grey box indicates the mean value ± 2 SD of the patients with Wigle’s score <8. Hypertrophy and diastolic function in hypertrophic cardiomyopathy
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(25). Besides, they did not explore Doppler pulmonary
vein flow velocities that complement transmitral
Doppler flow velocity in the assessment of increased
chamber stiffness (26). Moreover, in a previous study
(10), using M-mode echocardiography techniques, they
found a relation between the extent of LVH and impaired
relaxation. 
Wigle’s score and other indexes of LV hyper-
trophy
We evaluated LV hypertrophy by different indexes.
Such indices try to overcome the heterogeneity of LVH
in HCM by adding wall thickness in different regions (9),
or consider only maximal wall thickness (15), or even
count the number of hypertrophied segments (10). This
approach is empirical and reflects the inadequacy of LV
mass measurement in HCM. The traditional and validat-
ed formula by Devereaux and Reichek (8) cannot be
used: in HCM, the catenoidal shape of the septum and
of the heterogeneity in wall thickness imply that LV cav-
ity is not an ellipsoid; hence, the conceptual assumption
Devereaux and Reichek’s formula is based on is not cor-
rect. In principle, the only way to assess LV mass in
HCM should be magnetic resonance imaging; magnetic
resonance imaging is capable of identifying regions of
LV hypertrophy not readily recognized by echocardiog-
raphy (27). Wigle’s score is not a measure of LV mass,
however, it takes into consideration the distribution and
the extent of LVH in a semiquantitative way. Wigle’s
score was related to invasive indexes of passive dias-
tolic dysfunction, namely filling pressure (peak V wave
of pulmonary artery wedge pressure), end-diastolic
pressure, and the constant of chamber stiffness. The re-
lationship of passive diastolic dysfunction to Wigle’s
score (and the lack thereof of other indices of LVH) does
not imply itself that Wigle’s score better describes LVH
in HCM; this is also shown by the overlap in parameters
of diastolic function in the 2 hypertrophy subgroups. It
is to be noted, however, that patients with less hyper-
trophy (i.e. a Wigle’s score < 8) are very likely to have
normal diastolic function. In contrast, the subgroup
of patients with higher degrees of hypertrophy in-
clude subjects with depressed or still normal dias-
tolic function.
HCM patients with severe LVH showed higher degree
of LV outflow tract gradient and a higher (albeit not sig-
nificant) incidence of significant (≥ 30 mm Hg) obstruc-
tion, which may influence the difference in diastolic
function in the 2 HCM patients group. However, we 
Fig. 4 - A) Constant of chamber stiffness (k) plotted as a function of the Wigle’s score. Curved lines show 95% confidence limits for the fit-
ted line. B) Individual values of LV constant of chamber stiffness (k) in patients with Wigle’s score <8 (open circles) and ≥8 (closed circles).
Closed squares with vertical bars represent mean value ± 1 SD. The grey box indicates the mean value ± 2 SD of the patients with Wigle’s
score <8. 
r=0.564Ciampi et al
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analyzed the HCM patients according to the presence
of LV outflow tract obstruction and we did not find any
differences in the invasive indexes of diastolic function
in HCM patients, with and without LV outflow tract ob-
struction.
In conclusion, Wigle’s score is the only index of LVH
that relates to invasive indices of diastolic function and
it helps categorize patients with HCM in terms of dias-
tolic dysfunction. 
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